Tissue-Link was founded with the mission of addressing the critical need for effective control of severe bleeding through advanced hemostatic solutions. Our innovative approach has led to the development of a breakthrough hemostat specifically designed for severe bleeding scenarios. Additionally, we have pioneered a unique platform technology that enables the binding of biologically active peptides and proteins to various dressing materials. This technology ensures that these components are tightly bound while fully preserving their biological activity. The potential applications of this patented technology are limitless, offering new possibilities across a wide range of industries and medical advancements.
